China Shineway Pharmaceutical Group Limited (FRA:C1S)

Germany flag Germany · Delayed Price · Currency is EUR
0.8150
+0.0050 (0.62%)
Last updated: Jun 6, 2025
-14.66%
Market Cap 632.30M
Revenue (ttm) 499.95M
Net Income (ttm) 111.17M
Shares Out n/a
EPS (ttm) 0.15
PE Ratio 5.69
Forward PE 6.24
Dividend 0.06 (7.05%)
Ex-Dividend Date Apr 30, 2025
Volume n/a
Average Volume 544
Open 0.8150
Previous Close 0.8100
Day's Range 0.8150 - 0.8150
52-Week Range 0.7850 - 1.2600
Beta n/a
RSI 47.44
Earnings Date Aug 29, 2025

About FRA:C1S

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, ortho... [Read more]

Industry Pharmaceutical Preparations
Founded 2002
Employees 3,220
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol C1S
Full Company Profile

Financial Performance

In 2024, FRA:C1S's revenue was 3.78 billion, a decrease of -16.35% compared to the previous year's 4.52 billion. Earnings were 840.05 million, a decrease of -13.35%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.